87
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Novel heteroannulated chromeno[3′,2′:5,6]pyrido[2,3-d]pyrido[2′,3′: 4,5][1,3]thiazolo[3,2-a]pyrimidines: synthesis, characterization and antimicrobial evaluation

ORCID Icon, , , &
Pages 201-214 | Received 02 Aug 2022, Accepted 14 Jan 2023, Published online: 30 Jan 2023
 

Abstract

The main aim of the current research is directed to find a suitable approach to construct a new annulated systems namely chromeno[3′,2′:5,6]pyrido[2,3-d]pyrido[2′,3′:4,5][1,3] thiazolo[3,2-a]pyrimidines. Treatment of 3-cyano-6,8-dimethylchromone with thiobarbituric acid gave chromeno[3′,2′:5,6]pyrido[2,3-d]pyrimidine, which upon treatment with chloroacetonitrile afforded 3-aminochromenopyridothiazolopyrimidine. Vilsmeier Haack formylation of the later compound produced the desired o-aminocarboxaldehyde derivative 4. Condensation of compound 4 with some active methylene nitriles namely malononitrile, cyanoacetamide, ethyl cyanoacetate, cyanoacetamide, N-phenyl-2-cyanoacetamide, 1H-benzimidazol-2-ylacetonitrile, and malononitrile dimer produced annulated compounds 5–10 (64–76% yields). Friedländer condensation of compound 4 with some active methylene ketones namely acetylacetone, ethyl cyanoacetate, diethyl malonate, and acetoacetanilide afforded annulated systems 12–15 (65–71% yields). During in vitro examination of the prepared compounds against antimicrobial activity, they appeared high activity against yeast, fungus strains and intermediate activity against all types of bacterial strains. The poly-functional product 10 exhibited notable efficiency against all types of the used microorganisms, while compound 4 present high activity against Gram-positive, yeast and fungus strains. Using spectral and analytical data, the structures of the newly synthesized products were inferred.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.